Related references
Note: Only part of the references are listed.Antiretrovirals, Methamphetamine, and HIV-1 Envelope Protein gp120 Compromise Neuronal Energy Homeostasis in Association with Various Degrees of Synaptic and Neuritic Damage
Ana B. Sanchez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study
Adriana Carvalhal et al.
JOURNAL OF NEUROVIROLOGY (2016)
Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients
Qing Ma et al.
JOURNAL OF NEUROVIROLOGY (2016)
HIV protease inhibitors disrupt astrocytic glutamate transporter function and neurobehavioral performance
Pornpun Vivithanaporn et al.
AIDS (2016)
HIV Non-Nucleoside Reverse Transcriptase Inhibitor Efavirenz Reduces Neural Stem Cell Proliferation In Vitro and In Vivo
Jingji Jin et al.
CELL TRANSPLANTATION (2016)
ABC transporters at the blood-brain barrier
Anne Mahringer et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Cerebral white matter integrity during primary HIV infection
Patrick W. Wright et al.
AIDS (2015)
Outcome of neuropsychiatric symptoms related to an antiretroviral drug following its substitution by nevirapine: the RELAX study
E. Pedrol et al.
HIV MEDICINE (2015)
Efavirenz alters mitochondrial respiratory function in cultured neuron and glial cell lines
Haryes A. Funes et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders
Brigid K. Jensen et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
Neurocognitive Change in the Era of HIV Combination Antiretroviral Therapy: The Longitudinal CHARTER Study
Robert K. Heaton et al.
CLINICAL INFECTIOUS DISEASES (2015)
Involvement of Nitric Oxide in the Mitochondrial Action of Efavirenz: A Differential Effect on Neurons and Glial Cells
Nadezda Apostolova et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Cognitive impairment in patients with AIDS - prevalence and severity
Crystal C. Watkins et al.
HIV AIDS-RESEARCH AND PALLIATIVE CARE (2015)
Dysregulation of Endoplasmic Reticulum Stress and Autophagic Responses by the Antiretroviral Drug Efavirenz
Luc Bertrand et al.
MOLECULAR PHARMACOLOGY (2015)
Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment
Edana Cassol et al.
AIDS (2014)
Overexpression of mitochondrial antioxidant manganese superoxide dismutase (MnSOD) provides protection against AZT- or 3TC-induced endothelial dysfunction
Mitzi Glover et al.
ANTIVIRAL RESEARCH (2014)
Impact of darunavir, atazanavir and lopinavir boosted with ritonavir on cultured human endothelial cells: beneficial effect of pravastatin
Martine Auclair et al.
ANTIVIRAL THERAPY (2014)
Cytokine secretion from brain macrophages infected with human immunodeficiency virus in vitro and treated with raltegravir
Erick T. Tatro et al.
BMC INFECTIOUS DISEASES (2014)
Neurological and Psychiatric Adverse Effects of Antiretroviral Drugs
Michael S. Abers et al.
CNS DRUGS (2014)
Lack of mitochondrial toxicity of darunavir, raltegravir and rilpivirine in neurons and hepatocytes: a comparison with efavirenz
Ana Blas-Garcia et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Verbal memory declines more rapidly with age in HIV infected versus uninfected adults
Talia R. Seider et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2014)
Early suppressive antiretroviral therapy in HIV infection is associated with measurable changes in the corpus callosum
Sean G. Kelly et al.
JOURNAL OF NEUROVIROLOGY (2014)
Brain viral burden, neuroinflammation and neurodegeneration in HAART-treated HIV positive injecting drug users
Donald B. Smith et al.
JOURNAL OF NEUROVIROLOGY (2014)
Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system
Cagla Akay et al.
JOURNAL OF NEUROVIROLOGY (2014)
Decreased hippocampal volume and increased anxiety in a transgenic mouse model expressing the human CYP2C19 gene
A. Persson et al.
MOLECULAR PSYCHIATRY (2014)
Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions
Ellen C. Caniglia et al.
NEUROLOGY (2014)
Reduction of the HIV Protease Inhibitor-Induced ER Stress and Inflammatory Response by Raltegravir in Macrophages
Xiaoxuan Zhang et al.
PLOS ONE (2014)
Long-Term Exposure of Mice to Nucleoside Analogues Disrupts Mitochondrial DNA Maintenance in Cortical Neurons
Yulin Zhang et al.
PLOS ONE (2014)
Efavirenz Promotes β-Secretase Expression and Increased Aβ1-40,42 via Oxidative Stress and Reduced Microglial Phagocytosis: Implications for HIV Associated Neurocognitive Disorders (HAND)
Lecia A. M. Brown et al.
PLOS ONE (2014)
Efavirenz Induces Neuronal Autophagy and Mitochondrial Alterations
Phillip R. Purnell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy
Renaud A. Du Pasquier et al.
AIDS (2013)
Pharmacokinetics of Phase I Nevirapine Metabolites following a Single Dose and at Steady State
Patty Fan-Havard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Role of P-glycoprotein in the efflux of raltegravir from human intestinal cells and CD4+T-cells as an interaction target for anti-HIV agents
Yumi Hashiguchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
CSF Penetration by Antiretroviral Drugs
Christine Eisfeld et al.
CNS DRUGS (2013)
In Vitro Analysis and Quantitative Prediction of Efavirenz Inhibition of Eight Cytochrome P450 (CYP) Enzymes: Major Effects on CYPs 2B6, 2C8, 2C9 and 2C19
Cong Xu et al.
DRUG METABOLISM AND PHARMACOKINETICS (2013)
Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect
Birgit Grund et al.
JOURNAL OF NEUROVIROLOGY (2013)
Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy
Assawin Gongvatana et al.
JOURNAL OF NEUROVIROLOGY (2013)
Impact of pharmacogenetics on CNS side effects related to efavirenz
Almudena Sanchez Martin et al.
PHARMACOGENOMICS (2013)
Brain injury caused by HIV protease inhibitors: Role of lipodystrophy and insulin resistance
Sunita Gupta et al.
ANTIVIRAL RESEARCH (2012)
Psychological stress is associated with high levels of IL-6 in HIV-1 infected individuals on effective combined antiretroviral treatment
Carmina R. Fumaz et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120
Lucia Lisi et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Antiretroviral neurotoxicity
Kevin Robertson et al.
JOURNAL OF NEUROVIROLOGY (2012)
Impact of HIV and aging on neuropsychological function
Lauren A. Wendelken et al.
JOURNAL OF NEUROVIROLOGY (2012)
Dendritic Spine Injury Induced by the 8-Hydroxy Metabolite of Efavirenz
Luis B. Tovar-y-Romo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
The Dual Role of Pharmacogenetics in HIV Treatment: Mutations and Polymorphisms Regulating Antiretroviral Drug Resistance and Disposition
Veronique Michaud et al.
PHARMACOLOGICAL REVIEWS (2012)
Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort
Marlene Smurzynski et al.
AIDS (2011)
Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection
Calvin Cohen et al.
AIDS (2011)
TNFα is involved in neuropathic pain induced by nucleoside reverse transcriptase inhibitor in rats
Xuexing Zheng et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Clinical Pharmacokinetic and pharmacodynamic Profile of the HIV Integrase Inhibitor Elvitegravir
Srinivasan Ramanathan et al.
CLINICAL PHARMACOKINETICS (2011)
Long-Term Safety from the Raltegravir Clinical Development Program
Hedy Teppler et al.
CURRENT HIV RESEARCH (2011)
Highly active antiretroviral therapy drug combination induces oxidative stress and mitochondrial dysfunction in immortalized human blood-brain barrier endothelial cells
Kalyan Reddy Manda et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Protease inhibitor monotherapy and the CNS: peace of mind?
Ignacio Perez-Valero et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Human Immunodeficiency Virus Infection of Human Astrocytes Disrupts Blood-Brain Barrier Integrity by a Gap Junction-Dependent Mechanism
Eliseo A. Eugenin et al.
JOURNAL OF NEUROSCIENCE (2011)
Brain-Derived Neurotrophic Factor Modulates Antiretroviral-Induced Mechanical Allodynia in the Mouse
Cynthia L. Renn et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Pharmacotoxicology of monocyte-macrophage nanoformulated antiretroviral drug uptake and carriage
Rafael F. Bressani et al.
NANOTOXICOLOGY (2011)
Antiretroviral therapy CNS penetration and HIV-1-associated CNS disease
L. Garvey et al.
NEUROLOGY (2011)
Molecular pathogenesis of blood-brain barrier breakdown in acute brain injury
S. Nag et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2011)
Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: Implications for HIV-associated neurocognitive disorders
Brian Giunta et al.
MOLECULAR BRAIN (2011)
Significant Effects of Antiretroviral Therapy on Global Gene Expression in Brain Tissues of Patients with HIV-1-Associated Neurocognitive Disorders
Alejandra Borjabad et al.
PLOS PATHOGENS (2011)
Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs
Puneet Sharma et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
Samanta Simioni et al.
AIDS (2010)
Oral uridine supplementation antagonizes the peripheral neuropathy and encephalopathy induced by antiretroviral nucleoside analogues
Nils Venhoff et al.
AIDS (2010)
Clinical perspective on antiretroviral drug-drug interactions with the non-nucleoside reverse transcriptase inhibitor etravirine
Thomas N. Kakuda et al.
ANTIVIRAL THERAPY (2010)
Non-nucleoside reverse transcriptase inhibitor efavirenz increases monolayer permeability of human coronary artery endothelial cells
Md Saha Jamaluddin et al.
ATHEROSCLEROSIS (2010)
Ubisol-Aqua™: Coenzyme Q10 Prevents Antiretroviral Toxic Neuropathy in an In Vitro Model
Catherine L. Cherry et al.
CURRENT HIV RESEARCH (2010)
Enhancing the Delivery of Anti Retroviral Drug “Saquinavir” Across the Blood Brain Barrier Using Nanoparticles
Supriya D. Mahajan et al.
CURRENT HIV RESEARCH (2010)
Alcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms
Luiz F. Ferrari et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
CYP2C19 Genetic Variants Affect Nelfinavir Pharmacokinetics and Virologic Response in HIV-1-Infected Children Receiving Highly Active Antiretroviral Therapy
Akihiko Saitoh et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
Chronic exposure to nicotine and saquinavir decreases endothelial Notch-4 expression and disrupts blood-brain barrier integrity
Vamshi K. Manda et al.
JOURNAL OF NEUROCHEMISTRY (2010)
The blood-brain barrier and immune function and dysfunction
William A. Banks et al.
NEUROBIOLOGY OF DISEASE (2010)
Structure and function of the blood-brain barrier
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE (2010)
Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons
E. J. Wright et al.
NEUROLOGY (2010)
Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort
K. R. Robertson et al.
NEUROLOGY (2010)
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER Study
R. K. Heaton et al.
NEUROLOGY (2010)
Progressive Mitochondrial Compromise in Brains and Livers of Primates Exposed In Utero to Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
Rao L. Divi et al.
TOXICOLOGICAL SCIENCES (2010)
The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters
Olena Kis et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance
Christina M. Marraa et al.
AIDS (2009)
Roles and Mechanisms of Human Immunodeficiency Virus Protease Inhibitor Ritonavir and Other Anti-Human Immunodeficiency Virus Drugs in Endothelial Dysfunction of Porcine Pulmonary Arteries and Human Pulmonary Artery Endothelial Cells
Xinwen Wang et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3
Rajgopal Govindarajan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Long-Term Exposure to AZT, but not d4T, Increases Endothelial Cell Oxidative Stress and Mitochondrial Dysfunction
Erik R. Kline et al.
CARDIOVASCULAR TOXICOLOGY (2009)
Drug Interactions with New and Investigational Antiretrovirals
Kevin C. Brown et al.
CLINICAL PHARMACOKINETICS (2009)
PPARα and PPARγ attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities
Wen Huang et al.
FASEB JOURNAL (2009)
Neurodegeneration and Ageing in the HAART Era
Bruce J. Brew et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2009)
Neuropsychological Functioning and Antiretroviral Treatment in HIV/AIDS: A Review
Lucette A. Cysique et al.
NEUROPSYCHOLOGY REVIEW (2009)
The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs
Sarah Shugarts et al.
PHARMACEUTICAL RESEARCH (2009)
Exacerbation of depression associated with starting raltegravir: a report of four cases
Marianne Harris et al.
AIDS (2008)
A Report on the Effect of Commencing Enfuvirtide on Peripheral Neuropathy
Catherine L. Cherry et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2008)
Human Immunodeficiency Virus Protease Inhibitors and Risk for Peripheral Neuropathy
Ronald J. Ellis et al.
ANNALS OF NEUROLOGY (2008)
Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir
Aline Grigorian et al.
BMC NEUROSCIENCE (2008)
Maraviroc:: in vitro assessment of drug-drug interaction potential
Ruth Hyland et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Effects of CYP3A4 inducers with and without CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers
Samantha Abel et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
CYP2B6: New insights into a historically overlooked cytochrome P450 isozyme
Hongbing Wang et al.
CURRENT DRUG METABOLISM (2008)
HIV's double strike at the brain: neuronal toxicity and compromised neurogenesis
Marcus Kaul
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Efavirenz Induces CYP2B6-Mediated Hydroxylation of Bupropion in Healthy Subjects
Sarah M. Robertson et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction
Erik R. Kline et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2008)
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
LANCET (2008)
The blood-brain barrier in health and chronic neurodegenerative disorders
Berislav V. Zlokovic
NEURON (2008)
Effects of the HIV treatment drugs nevirapine and efavirenz on brain creatine kinase activity
Emilio L. Streck et al.
METABOLIC BRAIN DISEASE (2008)
Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
Sarah Palmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier
Anathbandhu Chaudhuri et al.
BLOOD (2008)
Neurotoxicity caused by didanosine on cultured dorsal root ganglion neurons
H. Liu et al.
CELL BIOLOGY AND TOXICOLOGY (2008)
Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome P4502B6*6 and*26
Hiroyuki Gatanaga et al.
CLINICAL INFECTIOUS DISEASES (2007)
Updated research nosology for HIV-associated neurocognitive disorders
A. Antinori et al.
NEUROLOGY (2007)
Expression and function of cytochrome P450 in brain drug metabolism
R. P. Meyer et al.
CURRENT DRUG METABOLISM (2007)
Molecular mechanisms of HIV protease inhibitor-induced endothelial dysfunction
Xinwen Wang et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Nucleoside reverse transcriptase inhibitors and human immunodeficiency virus proteins cause axonal injury in human dorsal root ganglia cultures
Barry Robinson et al.
JOURNAL OF NEUROVIROLOGY (2007)
HIV-1 gp120 compromises blood-brain barrier integrity and enhance monocyte migration across blood-brain barrier: implication for viral neuropathogenesis
Georgette D Kanmogne et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Mechanisms of pharmacokinetic and pharmacodynamic drug interactions associated with ritonavir-enhanced tipranavir
Manoli Vourvahis et al.
PHARMACOTHERAPY (2007)
Blood-brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions
Yuri Persidsky et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2006)
Cytochrome P4503A: Evidence for mRNA expression and catalytic activity in rat brain
Sanjay Yadav et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2006)
Metabolism of efavirenz and 8-hydroxyefavirenz by P4502B6 leads to inactivation by two distinct mechanisms
Namandje N. Bumpus et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy
Iain C. Anthony et al.
ACTA NEUROPATHOLOGICA (2006)
Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: Protease inhibitor-mediated neurotoxicity
JA Pettersen et al.
ANNALS OF NEUROLOGY (2006)
Developments in HIV neuropathogenesis
JA Rumbaugh et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Neuropsychiatric complications of antiretroviral therapy
Michelle S. Cespedes et al.
DRUG SAFETY (2006)
Gamma interferon primes productive human immunodeficiency virus infection in astrocytes
D Carroll-Anzinger et al.
JOURNAL OF VIROLOGY (2006)
Differential inhibition of cytochrome P450 3A4, 3A5 and 3A7 by five human immunodeficiency virus (HIV) protease inhibitors in vitro
MT Granfors et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
HIV protease inhibitor ritonavir increases endothelial monolayer permeability
CY Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus
S Kramer-Hämmerle et al.
VIRUS RESEARCH (2005)
Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients
DA Green et al.
AIDS (2005)
Mechanisms of the blood-brain barrier disruption in HIV-1 infection
M Toborek et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2005)
Efavirenz induces depressive-like behaviour, increased stress response and changes in the immune response in rats
SM O'Mahony et al.
NEUROIMMUNOMODULATION (2005)
Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells
IE Andras et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future
M Ingelman-Sundberg
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Enfuvirtide: A fusion inhibitor for the treatment of HIV infection
HB Fung et al.
CLINICAL THERAPEUTICS (2004)
Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs
YR Lai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Homozygous CYP2B6 *6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens
K Tsuchiya et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Endothelial cell-to-cell junctions: Molecular organization and role in vascular homeostasis
G Bazzoni et al.
PHYSIOLOGICAL REVIEWS (2004)
The blood-brain barrier: an overview - Structure, regulation, and clinical implications
P Ballabh et al.
NEUROBIOLOGY OF DISEASE (2004)
Notch activation induces endothelial cell cycle arrest and participates in contact inhibition:: Role of p21Cip1 repression
M Noseda et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells
IE András et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
The cytochrome P4502B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: Implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity
BA Ward et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America
JP Lalezari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia
A Lazzarin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Lopinavir: acute exposure inhibits P-glycoprotein; extended exposure induces P-glycoprotein
D Vishnuvardhan et al.
AIDS (2003)
Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questions
W Lewis
ANTIVIRAL RESEARCH (2003)
Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: Implications for modulating arteriogenesis and angiogenesis
ZJ Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Nucleoside reverse transcriptase inhibitors impair endothelium-dependent relaxation by increasing superoxide
RL Sutliff et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
HIV protease inhibitor ritonavir induces cytotoxicity of human endothelial cells
DS Zhong et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Nevirapine-induced neuropsychiatric complications, a class effect of non-nucleoside reverse transcriptase inhibitors?
JF Morlese et al.
AIDS (2002)
Keeping a good pathway down: transcriptional repression of Notch pathway target genes by CSL proteins
EC Lai
EMBO REPORTS (2002)
Neuropsychiatric complications of nevirapine treatment
MEJ Wise et al.
BRITISH MEDICAL JOURNAL (2002)
HIV-associated cognitive impairment before and after the advent of combination therapy
N Sacktor et al.
JOURNAL OF NEUROVIROLOGY (2002)
Central nervous system toxicity and amprenavir oral solution
CW James et al.
ANNALS OF PHARMACOTHERAPY (2002)
CYP3A4-mediated hepatic metabolism of the HIV-1 protease inhibitor saquinavir in vitro
VA Eagling et al.
XENOBIOTICA (2002)
Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2′3′-dideoxycytidine (ddC)
MC Dalakas et al.
LABORATORY INVESTIGATION (2001)
Pathways to neuronal injury and apoptosis in HIV-associated dementia
M Kaul et al.
NATURE (2001)
Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir
RME van Praag et al.
AIDS (2000)
Share Paper
